WHC is still in active development. Read this to understand our approach.
depiction of VRNGXHJGMCJRSQ-UHFFFAOYSA-N.svg
tripsit

6-apdb

Verificar en tripsit

psychonaut

6-APDB

Verificar en psychonaut

isomerdesign

6-APDB

Verificar en isomerdesign

druglab

6-APDB

Verificar en druglab

wiki

6-APDB

Verificar en wiki

Data

InChI: InChI=1S/C11H15NO/c1-8(12)6-9-2-3-10-4-5-13-11(10)7-9/h2-3,7-8H,4-6,12H2,1H3

Sinónimos: 2,3-Dihydro-6-(2-aminopropyl)benzofuran,CHEMBL124055,6-Nprop-dbf,6-BENZOFURANETHANAMINE, 2,3-DIHYDRO-.ALPHA.-METHYL-, (+/-)-,6-(2-Aminopropyl)-2,3-dihydrobenzofuran,AC-8814,4-desoxy-mda,Q4641530,EMA-3,152623-93-3,O72F3CP4O8,6-(2-aminopropyl)2,3-dihydrobenzofuran,6-(2-aminopropyl)-2,3-dihydrobenzo[b]furan,4-Desoxy-MDA,BF6AP,6-APDB,1-(2,3-Dihydro-1-benzofuran-6-yl)propan-2-amine,6-Benzofuranethanamine,2,3-dihydro-a-methyl-,DTXSID60934559,J3.334.443K,1-(2,3-dihydro-1-benzofuran-6-yl)propan-2-amine,SCHEMBL2562965,AKOS025294580,UNII-O72F3CP4O8

Estimated data

Solubilidad: -1.8 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 83.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.